Research ArticleAutism Spectrum Disorder

A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism

See allHide authors and affiliations

Science Translational Medicine  08 May 2019:
Vol. 11, Issue 491, eaau7356
DOI: 10.1126/scitranslmed.aau7356

Article Information

vol. 11 no. 491

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication July 13, 2018
  • Resubmitted October 30, 2018
  • Accepted for publication January 26, 2019
  • .

Article Versions

Author Information

  1. Karen J. Parker1,*,
  2. Ozge Oztan1,
  3. Robin A. Libove1,
  4. Noreen Mohsin1,
  5. Debra S. Karhson1,
  6. Raena D. Sumiyoshi1,
  7. Jacqueline E. Summers1,
  8. Kyle E. Hinman1,
  9. Kara S. Motonaga2,
  10. Jennifer M. Phillips1,
  11. Dean S. Carson1,
  12. Lawrence K. Fung1,
  13. Joseph P. Garner1,3 and
  14. Antonio Y. Hardan1
  1. 1Department of Psychiatry and Behavioral Sciences, Stanford University, Stanford, CA 94305, USA.
  2. 2Department of Pediatrics, Stanford University, Stanford, CA 94305, USA.
  3. 3Department of Comparative Medicine, Stanford University, Stanford, CA 94305, USA.
  1. *Corresponding author. Email: kjparker{at}stanford.edu

Altmetric

Article usage

Article usage:

No statistics are available.

Stay Connected to Science Translational Medicine